Fsb Premier Wealth Management, Inc. Spectrum Pharmaceuticals Inc Transaction History

Fsb Premier Wealth Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 Apr 14, 2022	SELL	$0.63 - $1.59 $126,000 - $318,000	-200,000 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$1.27 - $2.42 $254,000 - $484,000	200,000 New	200,000 $254,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Fsb Premier Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fsb Premier Wealth Management, Inc. with notifications on news.